BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34490987)

  • 1. Cryptic insertion of CBFB into MYH11 leading to a type D fusion in acute myeloid leukemia with normal karyotype.
    Yamamoto K; Kurata K; Kitao A; Sakai R; Matsumoto S; Matsumoto H; Saegusa J; Yakushijin K; Minami H
    Int J Lab Hematol; 2022 Feb; 44(1):e36-e39. PubMed ID: 34490987
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
    Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
    Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetically masked
    Ducourneau B; Fenwarth L; Duployez N; Lambert J; Struski S; Luquet I; Daudignon A; Helevaut N; Ruminy P; Preudhomme C; Terre C
    Leuk Lymphoma; 2020 Jul; 61(7):1772-1774. PubMed ID: 32223488
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
    Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
    Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bundles of Auer rods in maturing myeloid cells in a case of acute myeloid leukaemia with CBFB::MYH11 rearrangement and concomitant KIT mutation.
    Li THS; Lau WP; Ng KY; Wong WS
    Pathology; 2024 Apr; 56(3):455-457. PubMed ID: 37923609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute myeloid leukemia with type I CBFB::MYH11 fusion gene not detected by screening test for leukemia-related chimeric genes].
    Utsumi S; Shima T; Kubara C; Semba Y; Hayashi M; Takigawa K; Yoshino T; Minami M; Matsuo Y; Kuriyama T; Akashi K; Maeda T; Taniguchi S; Eto T
    Rinsho Ketsueki; 2023; 64(12):1503-1507. PubMed ID: 38220149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
    Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
    Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual exclusivity between the fusion gene CBFB::MYH11 and somatic mitochondrial mutations in acute myeloid leukaemia.
    Zhao C; Wang S; Wang K
    Br J Haematol; 2022 Nov; 199(4):e25-e29. PubMed ID: 36039018
    [No Abstract]   [Full Text] [Related]  

  • 9. TET2 deficiency cooperates with CBFB-MYH11 to induce acute myeloid leukaemia and represents an early leukaemogenic event.
    Reckzeh K; Estruch M; Ali M; Søgaard Helbo A; Mosbech A; Jae Won K; Rücker F; Döhner K; Theilgaard-Mönch K
    Br J Haematol; 2022 Apr; 197(2):201-206. PubMed ID: 35128634
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of leukemia progression in the Cbfb-MYH11 knockin mice by single cell RNA sequencing.
    Diemer JL; Yu K; Kelly M; Zhen T; Anderson S; Lopez G; Liu P
    Leukemia; 2023 Jul; 37(7):1549-1553. PubMed ID: 37225965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of a new method for screening of CBFB-MYH11 fusion gene in acute myeloid leukemia and its value in clinical use].
    Chen C; Li ZP; Lu QY; Liu ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1077-81. PubMed ID: 23114122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias.
    Ommen HB; Schnittger S; Jovanovic JV; Ommen IB; Hasle H; Østergaard M; Grimwade D; Hokland P
    Blood; 2010 Jan; 115(2):198-205. PubMed ID: 19901261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
    Biernacki MA; Foster KA; Woodward KB; Coon ME; Cummings C; Cunningham TM; Dossa RG; Brault M; Stokke J; Olsen TM; Gardner K; Estey E; Meshinchi S; Rongvaux A; Bleakley M
    J Clin Invest; 2020 Oct; 130(10):5127-5141. PubMed ID: 32831296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits.
    Park TS; Lee ST; Song J; Lee KA; Lee JH; Kim J; Lee HJ; Han JH; Kim JK; Cho SR; Choi JR
    Cancer Genet Cytogenet; 2009 Mar; 189(2):87-92. PubMed ID: 19215788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes.
    Huang BJ; Smith JL; Wang YC; Taghizadeh K; Leonti AR; Ries RE; Liu Y; Kolekar P; Tarlock K; Gerbing R; Crowgey E; Furlan SN; Shaw TI; Hagiwara K; Wei L; Cooper TM; Gamis AS; Aplenc R; Kolb EA; Farrar JE; Triche T; Alonzo TA; Ma X; Meshinchi S
    Blood Adv; 2021 Dec; 5(23):4963-4968. PubMed ID: 34547772
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidental identification of inv(16)(p13.1q22)/
    Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
    Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis.
    Duan W; Liu X; Jia J; Wang J; Gong L; Jiang Q; Zhao T; Wang Y; Zhang X; Xu L; Zhao X; Qin Y; Shi H; Chang Y; Huang X; Jiang H
    Br J Haematol; 2021 Jan; 192(2):265-271. PubMed ID: 32588434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cryptic insertion of CBFB into MYH11: importance of FISH probe design.
    Bidet A; Laharanne E; Struski S; Luquet I; Lippert E
    Cancer Genet; 2014; 207(10-12):516-7. PubMed ID: 25458460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.